AVROBIO, Inc. logo

AVROBIO, Inc.

AVROBIO, Inc. is a clinical stage company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”AVRO” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.avrobio.com
Founded2015
Disease Focus
Development Stage
STOCK CODENASDAQ: AVRO
Address
One Kendall Square,Building 300, Suite 201, MA 02139
Cambridge
United States
Email
Contact Number
+1 617 914 8420

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/avrobio” connections=”true” suffix=””]